Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$52.32
+0.48%
Mkt Cap $13.10B
Analyst Ratings
Buy
6
Hold
9
Sell
0
Price Target (53 analysts)
$44.11
Range $30.00 – $54.00
Implied Upside
-15.7%
Consensus $44.11 vs current $52.32
NASDAQ·Healthcare·Biotechnology
$52.32
+0.48%
Mkt Cap $13.10B
Buy
6
Hold
9
Sell
0
Price Target (53 analysts)
$44.11
Range $30.00 – $54.00
-15.7%
Consensus $44.11 vs current $52.32